The reversal of Epstein Barr virus induced hepatosplenomegaly in 24 hours with inhibitors of xanthine oxidase and nitric oxide synthase.
Flavin-Koenig
D F
DF
D000998:Antiviral Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019695:Glycyrrhizic Acid; D006529:Hepatomegaly / Q000188:drug therapy*; D006566:Herpesviridae Infections / Q000188:drug therapy*; D004854:Herpesvirus 4, Human; D006801:Humans; D008297:Male; D008715:Methionine / Q000627:therapeutic use*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D013163:Splenomegaly / Q000188:drug therapy*; D013997:Time Factors; D014412:Tumor Virus Infections / Q000188:drug therapy*; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors*
D000998:Antiviral Agents; D019695:Glycyrrhizic Acid; D008715:Methionine; D019001:Nitric Oxide Synthase; D014969:Xanthine Oxidase; D006034:Glycyrrhetinic Acid